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Summary. The human gene encoding the myogenic de· 
termination factor myf3 (mouse MyoD1) has been map-
ped to the short arm of chromosome 11. Analysis of sev-
eral somatic cell hybrids containing various derivatives 
with deletions or translocations revealed that the human 
MyoD (MYF3) geneisnot associated with the WAGR 
locus at chromosomal band 11pl3 nor with the loss of the 
heterozygosity region at 11p15.5 related to the Beckwith-
Wiedemann syndrome. Subregional mapping by in situ 
hybridization with an myf3 specific probe shows that the 
gene resides at the chromosomal band llp14, possibly at 
llp14.3. 
Introducdon 
Myogenic determination factors are muscle .. specific reg-
ulatory proteins that have been identified by their capac-
ity to initiate the myogenic program in mouse C3H 10Tl/2 
embryonie fibroblasts, thereby converting them into myo-
blasts (Davis et al. 1987). Wehave recently reported the 
identification of four distinct human cDNA clones en-
coding the factors myf3 to myf6, which individually or in 
concert are capable of generating the myogenic pheno-
type in non-muscle cells (Braun et al. 1989a, b and 1990). 
Nucleotide sequence analysis revealed that all four pro-
teins shared a highly conserved sequence motif coding 
for a putative helix·loop-helix structure. This sequence 
element required for biological activity was also present 
in other regulatory genes, such as the immunoglobulin 
enhancer binding proteins E12 and E47 (Murre et al. 
1989) and the proto.oncogenes of the myc family (Caudy 
et al. 1988). The cDNA clone myf3 constitutes the hu-
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man homolog of the mouse MyoD1 cDNA, and the cor-
responding human gene was shown tobe localized on 
the short arm of human chromosome 11 (Tapscott et al. 
1988; Braun et al. 1989b). 
Restrietion fragment length polymorphism (RFLP) 
analysis of childhood tumors such as rhabdomyosarcoma, 
Wilms tumor, adrenocortical carcinomas and hepato-
blastomas has suggested that the appearance of these 
tumor types is associated with tumor cell-specific loss of 
heterozygosity for chromosome 11 (Koufos et al. 1984, 
1985; Henry et al. 1989a). The Beckwith-Wiedemann 
syndrome, a rare condition of growth abnormalities, has 
also been cytogenetically located on chromosome 11 p 
(Waziri et al. 1983) and physically and genetically map-
ped to llp15.5 (Koufos et al. 1989, Henry et al. 1989b; 
Ping et al. 1989). Individuals with Beckwith-Wiedemann 
syndrome carry an increased risk for the same three em-
bryonic tumors (Sotelo-Avila and Gooch 1976). Further-
more, it has been recognized that mothers of children 
with rhabdomyosarcoma frequently develop breast can-
cer (Li and Fraumeni 1969; Strong et al. 1987). A second 
region on chromosome 11p13 has been implicated in the 
development of Wilrns' tumor based on constitutional 
deletions seen in individuals with the WAGR syndrome 
{Wilms tumor, aniridia, genitourinary anomalies, and 
mental retardation) (Riccardi et al. 1978; Francke et al. 
1979). Similar deletions of chromosome llpl3, limited 
to tumor cells, have been detected in sporadic Wilms' tu-
mors (Kaneko et al. 1981). More recently, long range 
physical maps ofthe WAGR region have been establish-
ed; these Iead to a precise localization of the genes 
for Wilms' tumor {WT) and aniridia {AN2) at 11p13 
(Compton et al. 1988; Gessler and Bruns 1989; Gessler 
et al. 1989b). 
The human MyoD gene based on its chromosomal 
localization, its biological activity in cell differentiation 
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and growth control, and its structural similarity to the 
myc proto-oncogenes, could well play a significant role 
in the development of the different abnormalities and 
tumor types mentioned above. In addition, few expres-
sed sequences specific to this area of chromosome 11 
have been described. W e therefore undertook the de-
tailed regional mapping of the human MyoD gene. 
Materials and methods 
Celllines and Southem blot analysis 
Somatic cell hybrids with WAGR deletions (N.W., M.J.) and a 
translocation involving llpl3 (POR4 from V. v. Heyningen) have 
been described previously (Poneous et al. 1987). Celllines GM5518 
and GM3808 (NIGMS Human Genetic Mutant Cell Repository, 
Camden, N. J.) carry hemizygous deletions of the W AGR region 
and were analyzed by gene dosage analysis (Gessler et al. 1989a). 
The cell hybrid PEL16 contains llp15 .4-pter lacking the telomeric 
part of the shon arm, and PEL40 constitutes a reciprocal translo-
cation carrying llpl5.4-pter (Henry et al. 1989a). Bid7 cells carry 
the deletion llp12-llpl4.dist. (Couillin et al. 1989). Extraction of 
DNA, preparation of Southem blots, and hybridization conditions 
have previously been described (Gessler et al. 1989a). A 830-bp 
cDNA fragment specific for MYF3 (Braun et al. 1989b) was used 
as a probe. 
Preparation of Chromosomes and in situ hybridization 
Human peripherallymphocytes were stimulated for growth in cul-
ture with. phytohemagglutinin (PHA). Chromosomes were labeled 
with bromodeoxyuridine (20 J.Lg/ml) for 6.5 h and prepared accord-
ing to standard procedures. For in situ bybridization, slides were 
pretreated witb RNAse A (100 llg/ml) and chromosomes were de-
natured in 70% formamide, 2 x SSC at 7\fC for 2min. Tbe myf3 
cDNA fragment derived from the 3' untranslated region of the 
cDNA (50-200 ng) was labeled with 3H-d1TP and 3H-dCTP (50-
120 Ci/mmol) by Dick-translation to a specific activity of 2-5 x 107 
dpm/J.Lg DNA. Hybridization were carried out in 50% formamide, 
10% dextran sulfate, 2 x SSC, and 500 J.Lglml salmon sperm DNA 
at 40°C for 16 h. Following hybridization, slides were washed three 
times in 50% formamide, 2 x SSC at 42°C for 15 min each, and six 
times in 2 x SSC 42°C for 2min. Washing was continued for 2h in 
2 x SSC at room temperature. The slides were coated with llford 
L4 emulsion and developed after 2-4 weeks. Staining was per-
formed according to a modified fluorochrome-photolysis-tech-
nique (FPG; Epplen et al. 1975). The chromosomes were iden-
tified and th.e grain distribution recorded at the same time (Mattei 
et al. 1985). 
Results and disaassion 
In order to examine the precise localization of the hu· 
man MyoDl (MYF3) gene on the short arm of chromo· 
some 11, we analyzed DNA from celllines carrying vari-
ous derivatives of chromosome 11. The deletions encom-
pass the WAGR region in llp13 and extend telomeric or 
centromeric to different degrees. 
As shown in Fig. 1, specific hybridization signals were 
obtained with the radioactively labeled myf3 probe in 
DNA from cells canying one chromosome 11 homolog 
of patients N. W. and M.J.; these bomologs lack the re-
gions from proximal llp14 to distal llpl2 and from 
proximal 11pl4 to llp13, respectively. Gene dosage 
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Fig.l. Schematic representation of myf3 bybrid.ization to DNA 
from the indicated somatic cell hybtids. The stipled areas indicate 
the regions of human chromosome 11 present in tbe various cell 
lines. Plus and minus symbols indicate the hybridization signals of 
the myf3 probe per hemizygous chromosome 11 
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Fag.l. Schematic representation of MyoD1 and myf3 hybridiza-
tion to the indicated celllines. The locations of few selected mark-
er genes are shown. MyoDl and myf3 represent the homologous 
gene products from mouse and human, respectively 
analysis of DNA from celllines GM5518 and GM3808 
containing hemizygous deletions of the W AGR region 
extending far into llpl4 and llpl2 showed no evidence 
for a deletion of myfJ..specific sequences in both cases. 
In contrast, DNA from the POR4 hybrid that contained 
the llp13-llqter part of an aniridia-associated translo-
cation did not show hybridization with the myf3 probe. 
From these results, we conclude that the human MyoD 
gene is located in the region llp14-llpter and can be ex-
cluded from the WAGR locus at llp13. 
To study the moredistal region of chromosome llp 
in more detail, additional somatic cell hybrlds defming 
the smallest region of overlap of the Beckwith-Wiede-
mann locus were used (Henry et al. 1989b). PEL16lack-
ing llpl5.4-pter, and PEL40 containing the telomeric 
fragment of a reciprocal chromosome 11 translocation 
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with the breakpoint in llp15.4 were analyzed with the 
myf3 probe. As shown in Fig. 2, PEL16 containing the 
llp15.4-llqter shows positive hybridization with myf3 
and the mouse MyoDl probe, whereas the reciprocal 
fragment of the same chromosome present in PEL40 
cells cannot be detected by either probe. Another cell 
hybrid Bid7 (Coullin et al. 1989) with deletion break-
points in llp12 and llp14.3 also shows myf3-specific hy-
bridization, indicating that the myf3 gene maps to the re-
gion llp14.3 to llp15.4 and is certainly not associated 
with the Beckwith-Wiedemann region, which maps dis-
tal to the latter breakpoint. 
Additional support for the localization of the MyoD 
gene at llp14 came from in situ hybridization. From 24 
observed hybridization signals, 15 were located around 
llp14.3, the rest mapping in the adjacent areas (Fig. 3). 
This result, obtained by an independent technique, con-
firmed that the human MyoD gene encoding a myogenic 
determination factor maps to llp14 and is therefore not 
linked to either of the two genetic loci associated with 
sporadic or hereditary forms of embryonie tumors in 
children. This is in general agreement with recent results 
published by Scrable et al. (1990) who mapped the human 
MyoDl gene to llp15.4, a localization that is slightly 
moredistal than our sublocalization. It is interesting to 
note tbat the majority of rhabdomyosarcomas express 
detectable Ievels of myf3 (MyoDl) mRNA, irrespective 
of the losss or maintenance of beterozygosity at chromo-
some 11 (Scrable et al. 1989). Furthermore, it has been 
shown that the expression of the MyoDl (Myf3) muscle 
determination gene in human rhabdomyosarcomas is 
closely related to the capacity of these cells to differen-
tiate, but it does not define the malignancy of these tu-
mors (Hiti et al. 1989). 
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